Atlas Trials

Caffeine, CYPA12 and Resistance Training

Clinical trial NCT06610123 · COMPLETED

Trial details

NCT number
NCT06610123
Sponsor
University of Alcala
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
CYP1A2 PolymorphismCaffeine and Resistance Training
Start date
2024-04-01
Primary completion
2026-04-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.